Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,804
Award facts
- Contract value 100% obligated
- $52,803.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,803.53 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on December 31, 2025, with completion expected by January 2, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division, with performance to be fulfilled at the company's headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Mounjaro is a diabetes treatment medication commonly used within federal healthcare systems, including the Defense Health Agency and other military medical facilities. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical vendor within the DLA Medical Supply Chain, supplying a broad range of brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical procurement strategy includes plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the primary contractors supporting federal military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9JA1?
SPE2DR26F9JA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F9JA1 worth?
The government has obligated $52,804 on SPE2DR26F9JA1.
Is contract SPE2DR26F9JA1 an order under another contract?
Yes. SPE2DR26F9JA1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JA1 competed?
The extent of competition for SPE2DR26F9JA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award